Authors:
Lakkis, NM
George, S
Thomas, E
Ali, M
Guyer, K
Carville, D
Citation: Nm. Lakkis et al., Use of ICHOR-platelet works to assess platelet function in patients treated with GP IIb/IIIa inhibitors, CATHET C IN, 53(3), 2001, pp. 346-351
Authors:
Nagueh, SF
Ommen, SR
Lakkis, NM
Killip, D
Zoghbi, WA
Schaff, HV
Danielson, GK
Quinones, MA
Tajik, AJ
Spencer, WH
Citation: Sf. Nagueh et al., Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy, J AM COL C, 38(6), 2001, pp. 1701-1706
Authors:
Flores-Ramirez, R
Lakkis, NM
Middleton, KJ
Killip, D
Spencer, WH
Nagueh, SF
Citation: R. Flores-ramirez et al., Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy, J AM COL C, 37(1), 2001, pp. 208-214
Authors:
Nagueh, SF
Stetson, SJ
Lakkis, NM
Killip, D
Perez-Verdia, A
Entman, ML
Spencer, WH
Torre-Amione, G
Citation: Sf. Nagueh et al., Decreased expression of turner necrosis factor-alpha and regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy, CIRCULATION, 103(14), 2001, pp. 1844-1850
Authors:
Mazur, W
Nagueh, SF
Lakkis, NM
Middleton, KJ
Killip, D
Roberts, R
Spencer, WH
Citation: W. Mazur et al., Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy, CIRCULATION, 103(11), 2001, pp. 1492-1496
Authors:
Lakkis, NM
Nagueh, SF
Dunn, JK
Killip, D
Spencer, WH
Citation: Nm. Lakkis et al., Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: One-year follow-up, J AM COL C, 36(3), 2000, pp. 852-855
Authors:
Nagueh, SF
Lakkis, NM
Middleton, KJ
Killip, D
Zoghbi, WA
Quinones, MA
Spencer, WH
Citation: Sf. Nagueh et al., Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy, J AM COL C, 34(4), 1999, pp. 1123-1128
Citation: Jk. Mickelson et al., Chimeric 7E3 Fab (ReoPro) decreases detectable CD11b on neutrophils from patients undergoing coronary angioplasty, J AM COL C, 33(1), 1999, pp. 97-106
Authors:
Nagueh, SF
Lakkis, NM
Middleton, KJ
Killip, D
Zoghbi, WA
Quinones, MA
Spencer, WH
Citation: Sf. Nagueh et al., Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy, CIRCULATION, 99(3), 1999, pp. 344-347
Authors:
Nagueh, SF
Lakkis, NM
Middleton, KJ
Spencer, WH
Zoghbi, WA
Quinones, MA
Citation: Sf. Nagueh et al., Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy, CIRCULATION, 99(2), 1999, pp. 254-261